Korean Drug

Korean Drug Co., Ltd. is a specialized South Korean pharmaceutical company founded in 1964, primarily focused on the import, distribution, and manufacturing of high-quality therapeutics. The company has established itself as a key partner for global pharmaceutical firms, bringing innovative treatments in respiratory, gastrointestinal, and cardiovascular medicine to the South Korean market. Beyond distribution, Korean Drug operates an R&D center dedicated to developing incrementally modified drugs (IMDs) and high-value generics. Their manufacturing facilities are GMP-certified, ensuring high standards for their diverse portfolio of cardiovascular, respiratory, and metabolic medications. With a robust sales network and a commitment to quality, the company serves a broad range of hospitals and clinics across the country. It is particularly recognized for its long-standing partnerships with European firms like Chiesi and Almirall.